Back to Search
Start Over
Suberanilohydroxamic acid prevents TGF-β1-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation.
- Source :
-
Biochimica et biophysica acta. Gene regulatory mechanisms [Biochim Biophys Acta Gene Regul Mech] 2018 May; Vol. 1861 (5), pp. 463-472. Date of Electronic Publication: 2018 Mar 17. - Publication Year :
- 2018
-
Abstract
- Cyclooxygenase-2 (COX-2), with its main antifibrotic metabolite PGE <subscript>2</subscript> , is regarded as an antifibrotic gene. Repressed COX-2 expression and deficient PGE <subscript>2</subscript> have been shown to contribute to the activation of lung fibroblasts and excessive deposition of collagen in pulmonary fibrosis. We have previously demonstrated that COX-2 expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) is epigenetically silenced and can be restored by epigenetic inhibitors. This study aimed to investigate whether COX-2 downregulation induced by the profibrotic cytokine transforming growth factor-β1 (TGF-β1) in normal lung fibroblasts could be prevented by epigenetic inhibitors. We found that COX-2 protein expression and PGE <subscript>2</subscript> production were markedly reduced by TGF-β1 and this was prevented by the pan-histone deacetylase inhibitor suberanilohydroxamic acid (SAHA) and to a lesser extent by the DNA demethylating agent Decitabine (DAC), but not by the G9a histone methyltransferase (HMT) inhibitor BIX01294 or the EZH2 HMT inhibitor 3-deazaneplanocin A (DZNep). However, chromatin immunoprecipitation assay revealed that the effect of SAHA was unlikely mediated by histone modifications. Instead 3'-untranslated region (3'-UTR) luciferase reporter assay indicated the involvement of post-transcriptional mechanisms. This was supported by the downregulation by SAHA of the 3'-UTR mRNA binding protein TIA-1 (T-cell intracellular antigen-1), a negative regulator of COX-2 translation. Furthermore, TIA-1 knockdown by siRNA mimicked the effect of SAHA on COX-2 expression. These findings suggest SAHA can prevent TGF-β1-induced COX-2 repression in lung fibroblasts post-transcriptionally through a novel TIA-1-dependent mechanism and provide new insights into the mechanisms underlying its potential antifibrotic activity.<br /> (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Adenosine administration & dosage
Adenosine analogs & derivatives
Azacitidine administration & dosage
Azacitidine analogs & derivatives
Cell Line
Cyclooxygenase 1 genetics
DNA Methylation genetics
Decitabine
Enhancer of Zeste Homolog 2 Protein genetics
Fibroblasts metabolism
Gene Expression Regulation genetics
Humans
Hydroxamic Acids administration & dosage
Lung drug effects
Lung metabolism
Promoter Regions, Genetic
Vorinostat
Cyclooxygenase 2 genetics
Histone Deacetylase Inhibitors administration & dosage
T-Cell Intracellular Antigen-1 genetics
Transforming Growth Factor beta1 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1874-9399
- Volume :
- 1861
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Biochimica et biophysica acta. Gene regulatory mechanisms
- Publication Type :
- Academic Journal
- Accession number :
- 29555582
- Full Text :
- https://doi.org/10.1016/j.bbagrm.2018.03.007